← Leaderboards
Christina M Wyatt
Icahn School Of Medicine At Mount Sinai
$11,078,328
Attributed
$17,970,109
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.4M · FY2007–24$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$17,970,109 · 6
By mechanism
U01$10,619,685 · 1
R01$3,946,543 · 2
U24$1,853,916 · 1
P01$849,872 · 1
K23$700,093 · 1
Top collaborators
- Hrishikesh Chakraborty9 shared
- Scott M Palmer3 shared
- Huiman X Barnhart2 shared
- Keisha L. Bentley-Edwards2 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Mone Zaidi$25,912,145
- Li Sun$3,167,852
- Suzanne Sharry Vang$686,555
- Christina Wang$383,876
Others in their field
Top investigators on “Participant”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$407,724,307
- Lawrence Corey · Fred Hutchinson Cancer Center$333,313,234
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
- Albert Lazzarini · California Institute Of Technology$300,431,866
Research focus
ParticipantProgramsResourcesHiv InfectionsProspectiveAntiretroviral TherapyMonitorBaseHigh RiskDesignKidney DiseasesDocumentationKidneyIncidenceEnsureRisk FactorsFutureClinical ResearchChronic Kidney FailureResearch PersonnelEnrollmentRecruitSpecimenSuccess
Grant awards (31)
The IGNITE II CC: Engagement, Coordination, Demonstration, and Dissemination$1,904,617
U01 · FY2024 · HG · contact PI
Interventions that Address Structural Racism to Reduce Kidney Health Disparities Research Coordinating Center$949,598
U24 · FY2024 · DK · contact PI
The IGNITE II CC: Engagement, Coordination, Demonstration, and Dissemination$663,271
U01 · FY2024 · HG · contact PI
The IGNITE II CC: Engagement, Coordination, Demonstration, and Dissemination$3,510,908
U01 · FY2023 · HG · contact PI
Interventions that Address Structural Racism to Reduce Kidney Health Disparities Research Coordinating Center$904,318
U24 · FY2023 · DK · contact PI
The IGNITE II CC: Engagement, Coordination, Demonstration, and Dissemination$1,423,655
U01 · FY2022 · HG · contact PI
The IGNITE II CC: Engagement, Coordination, Demonstration, and Dissemination$729,485
U01 · FY2022 · HG · contact PI
The IGNITE II CC: Engagement, Coordination, Demonstration, and Dissemination$311,784
U01 · FY2022 · HG · contact PI
The IGNITE II CC: Engagement, Coordination, Demonstration, and Dissemination$135,918
U01 · FY2022 · HG · contact PI
The IGNITE II CC: Engagement, Coordination, Demonstration, and Dissemination$1,572,689
U01 · FY2021 · HG · contact PI
The IGNITE II CC: Engagement, Coordination, Demonstration, and Dissemination$367,358
U01 · FY2021 · HG · contact PI
Impact of early antiretroviral therapy on kidney disease outcomes$312,487
R01 · FY2021 · DK · contact PI
Clinical Core (MSSM)$132,700
P01 · FY2021 · DK · contact PI
Impact of early antiretroviral therapy on kidney disease outcomes$404,139
R01 · FY2020 · DK · contact PI
Clinical Core (MSSM)$183,337
P01 · FY2020 · DK · contact PI
Impact of early antiretroviral therapy on kidney disease outcomes$547,026
R01 · FY2019 · DK · contact PI
Clinical Core (MSSM)$188,731
P01 · FY2019 · DK · contact PI
Impact of early antiretroviral therapy on kidney disease outcomes$391,258
R01 · FY2018 · DK · contact PI
Clinical Core (MSSM)$180,388
P01 · FY2018 · DK · contact PI
Impact of early antiretroviral therapy on kidney disease outcomes$453,239
R01 · FY2017 · DK · contact PI
Clinical Core (MSSM)$164,716
P01 · FY2017 · DK · contact PI
Incidence and Implications of Subclinical Kidney Injury with Tenofovir based PrEP$494,088
R01 · FY2016 · DK · contact PI
Incidence and Implications of Subclinical Kidney Injury with Tenofovir based PrEP$99,931
R01 · FY2016 · DK · contact PI
Incidence and Implications of Subclinical Kidney Injury with Tenofovir based PrEP$625,119
R01 · FY2015 · DK · contact PI
Incidence and Implications of Subclinical Kidney Injury with Tenofovir based PrEP$619,256
R01 · FY2014 · DK · contact PI
Kidney Disease in HIV-Hepatitis C Virus Co-Infection$129,465
K23 · FY2011 · DK · contact PI
Kidney Disease in HIV-Hepatitis C Virus Co-Infection$129,225
K23 · FY2010 · DK · contact PI
Kidney Disease in HIV-Hepatitis C Virus Co-Infection$53,968
K23 · FY2010 · DK · contact PI
Kidney Disease in HIV-Hepatitis C Virus Co-Infection$129,225
K23 · FY2009 · DK · contact PI
Kidney Disease in HIV-Hepatitis C Virus Co-Infection$129,225
K23 · FY2008 · DK · contact PI
Kidney Disease in HIV-Hepatitis C Virus Co-Infection$128,985
K23 · FY2007 · DK · contact PI